stonks4u
Sign up free
PETV logo

PETV PetVivo Holdings, Inc.

Other OTC · Medical - Devices · Healthcare

$0.68
-0.01 (-1.45%)

PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as…

Market Cap: $25.56Mwww.petvivo.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 14Aug 14

Quote

Day Range
$0.68 – $0.70
52-Week Range
$0.60 – $1.69
Volume
$407.00
Market Cap
$25.56M
50-Day Avg
$0.75
200-Day Avg
$0.89
Prev Close
$0.69
Open
$0.70

Valuation & Ratios

P/E Ratio
-1.94
EPS
$-0.35
P/B Ratio
9.60
P/S Ratio
18.49
Debt/Equity
0.17
Current Ratio
1.35
Dividend Yield
+1.9%
Gross Margin
+66.1%

Returns & Efficiency

Return on Equity
-476.2%
Return on Assets
-292.8%
FCF Yield
-29.0%
EV/EBITDA
-2.40

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2026$1.14M$-10.47M$-0.36
2025$1.13M$-8.40M$-0.41
2024$968.7K$-10.96M$-0.78
2023$917.2K$-8.70M$-0.85
2022$115.6K$-4.94M$-0.56

Social Signal Score

50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Wed, Nov 18(in 3 months)

Consensus estimate $-0.08 per share

1of 1 quarters beat consensus

Typical surprise +37.5% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Aug 14$-0.05 vs $-0.08beat

Estimates and results for PETV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

PETVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsglobenewswire.com·21h ago·Neutral

    … Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027 MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026.

    View source ↗